INVESTORS CAREERS RESOURCES All dates 2018 2019 2020 2021 01/09/2021 Letter to the Shareholders – September 2021 Here is our September issue which echoes our #InvestorDay 2021. As usual, Philippe Genne has concocted an editorial entitled “Little GrassHopper”: a philosophical angle on the meaning of life and the importance of the individual in society. 20/11/2020 Letter to our shareholders – November 2020 “Hunting in packs, a collaborative commercial approach hard-wired into Oncodesign’s genes” – Philippe Genne, President and CEO of Oncodesign. 01/04/2020 Letter to our shareholders – April 2020 Here is our April 2020 issue which details the new organization of the Group into 3 Business Units. Interviews and articles on the menu. Anatomy of the new face of Oncodesign: BU Service, BU Biotech & BU Artificial Intelligence. Without forgetting the editorial by Ph. Genne entitled “how much is… 01/11/2019 Letter to our shareholders – November 2019 “The alignment of planets is more topical than ever at the end of the year, with all due respect to the spell casters.” says Philippe Genne, CEO & founder, Oncodesign. 01/06/2019 Letter to our shareholders – June 2019 “The health sector is in great need of innovations, & will continue to be for a long time yet” says Philippe Genne, CEO & founder, Oncodesign. 01/11/2018 Letter to our shareholders – November 2018 “I urge you all to stay aboard and keep your eyes firmly fixed on the future: we believe in it” says Philippe Genne, CEO & founder, Oncodesign. 01/06/2018 Letter to our shareholders – June 2018 “Step by step, we are building our future with innovation” says Philippe Genne, CEO & founder, Oncodesign. Contact-us 18 rue Jean Mazen - FR - 21000 Dijon Tel.+33 380 788 260 Get in touch Science within easy reach! Receive our general letter or our financial news! Explore Oncodesign's vitality Legal notice Personal data policy